Wednesday, July 8, 2026
🇺🇸 FDA

pharma · COVID-19 · Hepatitis C · AVIR

Atea Pharmaceuticals

Atea Pharmaceuticals clinical programs — 25 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
225 Franklin St, Suite, 2100, Boston, Massachusetts 02110, US HQ
2014 Founded
57 Employees
Public company Type
AVIR · NYSE Ticker
Company details
Status
Public
HQ
225 Franklin St, Suite, 2100, Boston, Massachusetts 02110, US
Founded
2014
Employees
57
Programs
37
Drugs
29
Patents
35
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Atea Pharmaceuticals projects

25 ClinicalTrials.gov programs sponsored by Atea Pharmaceuticals.

Atea Pharmaceuticals has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

25 programs

Clinical programs

  1. AT-01B-006

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  2. AT-527

    Atea Pharmaceuticals

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  3. AT-527

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  4. AT-527

    Atea Pharmaceuticals

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  5. AT-527 (R07496998)

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  6. AT-527 + digoxin

    Atea Pharmaceuticals

    Healthy Volunteers Study

    phase 1 small molecule completed

    1 trial

  7. AT-527 550 mg + cyclosporine

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  8. AT-527 550 mg + midazolam

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  9. AT-527 Formulation 1

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  10. AT-527 fasted

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  11. AT-752

    Atea Pharmaceuticals

    Dengue

    phase 1 small molecule completed

    2 trials

  12. Bemnifosbuvir (BEM)

    Atea Pharmaceuticals

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  13. Bemnifosbuvir (BEM)

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    2 trials

  14. Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  15. Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combination

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule active

    1 trial

  16. Buprenorphine/Naloxone + BEM/RZR

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule active

    1 trial

  17. Cohort 1 BEM + Ruzasvir

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  18. Digoxin vs Digoxin + BEM/RZR vs Digoxin + 2h BEM/RZR

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  19. Drug: AT-527 + rosuvastatin

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  20. Ethinyl Estradioll/Levonorgestrel (EE/LNG)

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  21. GHB01L1

    Atea Pharmaceuticals

    Seasonal Human Influenza

    phase 1 mab completed

    1 trial

  22. GHB04L1

    Atea Pharmaceuticals

    Influenza

    phase 1 mab completed

    1 trial

  23. GHB04L1

    Atea Pharmaceuticals

    Influenza, Avian

    phase 1 mab completed

    1 trial

  24. Period 1: AT-527 550 mg

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  25. Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fasting

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Atea Pharmaceuticals have?

25 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.